Spotio

DECEMBER 30, 2024

By aligning sales, marketing, customer success, and finance, RevOps ensures your team is rowing in the same direction to drive sustainable growth. Revenue Operations (RevOps) connects the teams responsible for driving revenuemarketing, sales, customer success, and financeinto a seamless, unified system. What Is Revenue Operations?

Sales 52

Sales Prospecting CRM Leads 52

PM360

APRIL 7, 2023

Dan Renick The IRA presents market access teams with a unique opportunity to make recommendations to CMS regarding the evidence and methodology that will be applied in evaluating drugs for upcoming Medicare negotiations that will lead to price adjustments in 2026. Given the volume of 340B sales (13% of total U.S.

Manufacturing 97

Manufacturing Insurance Marketing Government 97

European Pharmaceutical Review

AUGUST 22, 2024

Based on their rising popularity to treat type 2 diabetes and obesity, GlobalData has predicted that sales of glucagon-like peptide-1 receptor (GLP-1R) drugs will increase fourfold to an estimated $142 billion by 2030. Eli Lilly shared that production of the medicines will commence at the Lebanon site towards the end of 2026.

Medicine 59

Medicine Marketing Manufacturing Sales 59

pharmaphorum

JANUARY 18, 2023

That pressure can lead to diagnostic errors, with a 2018 study suggesting that there are 40 million errors involving imaging worldwide every year. The business generated sales of €1.8 billion (approximately $1.9 billion) in 2021, around 10% of the group’s total healthcare revenues.

Medical 59

Medical Pharma Media Sales 59

pharmaphorum

JULY 5, 2022

Prior to this, he founded the industry-leading publication, pharmaphorum, in 2009, which also provides broader content communications and marketing services to enable more effective customer engagement.

Patients 98

Patients Medicine Marketing Recruitment 98

Clarivate

OCTOBER 25, 2023

The initial list, which takes effect in 2026, has the potential to roil formularies since it includes a mix of high-volume, preferred brands and a group of high-cost specialty drugs for autoimmune conditions (psoriasis) and cancer. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharmaceutical Technology

JANUARY 10, 2023

billion in sales in 2019, increasing to $136.2 billion in 2029, with drug sales almost doubling at a compound annual growth rate (CAGR) of 11.5%. Mounjaro is forecast to compete for significant market share with semaglutide and also Lilly’s Trulicity (dulaglutide), reaching peak sales of $10.2

Marketing 52

Marketing Physicians Sales Leads 52

PM360

APRIL 7, 2023

Pharma, formulary decision-makers, and contracting specialists must now track exact dates when drugs became available, then track the difference between average sales price (ASP) and Maximum Fair Price (MFP) to ensure provider reimbursement is correct.”

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

Pharmaceutical Technology

JANUARY 16, 2023

The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The entire pharma industry will be affected by the fallout.

Pharma 64

Pharma Pharmaceutical Manufacturing Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The entire pharma industry will be affected by the fallout.

Pharma 52

Pharma Pharmaceutical Manufacturing Marketing 52

Spotio

JUNE 6, 2022

More empowered buyers has resulted in longer sales cycles. And, 50-90% of the journey is complete before a buyer interacts with a sales rep. This shift in behavior should be taken seriously by any sales team, whether inside or out in the field. Here is a list of 130 sales statistics broken out across 20 categories.

Sales 111

Sales Prospecting B2B Sales Leads 111

PM360

SEPTEMBER 21, 2023

GoodRx is the leading platform 2 with the highest unaided awareness and trust across patients, physicians, and pharmacists 3 that Americans—regardless of insurance status—use across many phases of their healthcare journey. United States Specialty Pharmaceuticals Market & Forecast 2020-2026,” BusinessWire, December 8, 2020.

Prescription 52

Prescription Medical Patients Distribution 52

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. Furthermore, the 2020 post-pandemic launches, for which we now have up to 21 months of sales, show continued average underperformance.

Doctors 59

Doctors Medicine Marketing Sales 59

Infuse Medical

MARCH 12, 2025

Driving Success in Immersive Medical Sales Technology Selling complex medical devices has always been a challenge. Traditional sales methodssuch as brochures, PowerPoint presentations, and live demonstrationsoften fall short in conveying the full value, sophistication, and real-world application of these products.

Sales technology 130

Sales technology Medical sales Sales Medical 130

pharmaphorum

NOVEMBER 6, 2022

Worldwide, RSV infections lead to more than three million hospitalisations and almost 60,000 deaths in children under five years of age every year, with around half of fatalities in infants less than six months. AZ and Sanofi say they hope to launch the antibody next autumn, in time for the 2023/24 RSV season.

Marketing 65

Marketing Sales Manufacturing Pharma 65

Healthcare Success

JANUARY 27, 2025

Prioritize Education Over Sales Older adults and seniors prefer unbiased education over high-pressure sales tactics to make informed decisions. However, I've heard there are some rumors out there that there are some plans that will be entering the marketplace for 2025 to offer 2026 benefits. 18 exited last year.

Marketing 65

Marketing Education Media Leads 65

PM360

JANUARY 24, 2025

Dr. Mehmet Ozthe newly nominated CMS Administrator and well-known proponent of MAwould be unlikely to enact measures that promote standalone Part D plans, if he ends up leading the agency. nomination to lead the Department of Health & Human Services (HHS) and his stance on lifestyle modification for weight loss. Kennedy (RFK) Jr.s

Food and Drug Administration 52

Food and Drug Administration Manufacturing Insurance Pharmaceutical 52